Gut Microbiota Dysbiosis Induced by Intracerebral Hemorrhage Aggravates Neuroinflammation in Mice

Intracerebral hemorrhage (ICH) induces a strong hematoma-related neuroinflammatory reaction and alters peripheral immune homeostasis. Recent research has found that gut microbiota plays a role in neurodegeneration and autoimmune diseases by regulating immune homeostasis and neuroinflammation. Theref...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in microbiology Vol. 12; p. 647304
Main Authors Yu, Xiaobo, Zhou, Guoyang, Shao, Bo, Zhou, Hang, Xu, Chaoran, Yan, Feng, Wang, Lin, Chen, Gao, Li, Jianru, Fu, Xiongjie
Format Journal Article
LanguageEnglish
Published Frontiers Media S.A 06.05.2021
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Intracerebral hemorrhage (ICH) induces a strong hematoma-related neuroinflammatory reaction and alters peripheral immune homeostasis. Recent research has found that gut microbiota plays a role in neurodegeneration and autoimmune diseases by regulating immune homeostasis and neuroinflammation. Therefore, we investigated the relationship between ICH, microbiota alteration, and immune responses after hematoma-induced acute brain injury. In our study, we used a mouse model of ICH, and 16S ribosomal RNA sequencing showed that ICH causes gut microbiota dysbiosis, which in turn affects ICH outcome through immune-mediated mechanisms. There was prominent reduced species diversity and microbiota overgrowth in the dysbiosis induced by ICH, which may reduce intestinal motility and increase gut permeability. In addition, recolonizing ICH mice with a normal health microbiota ameliorates functional deficits and neuroinflammation after ICH. Meanwhile, cell-tracking studies have demonstrated the migration of intestinal lymphocytes to the brain after ICH. In addition, therapeutic transplantation of fecal microbiota improves intestinal barrier damage. These results support the conclusion that the gut microbiome is a target of ICH-induced systemic alteration and is considered to have a substantial impact on ICH outcome.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
This article was submitted to Microbial Immunology, a section of the journal Frontiers in Microbiology
Edited by: Takahiro Masuda, Kyushu University, Japan
These authors have contributed equally to this work
Reviewed by: Xiao-Yi Xiong, Chengdu University of Traditional Chinese Medicine, China; Liang Liu, Northern Theater General Hospital, China
ISSN:1664-302X
1664-302X
DOI:10.3389/fmicb.2021.647304